Дмитренко, І. В. (2018) “Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia”, Problems of Environmental Biotechnology, (1). doi: 10.18372/2306-6407.1.12851.